User profiles for "author:B Gerritse"
Bart GerritseMedtronic Bakken Research Center Verified email at medtronic.com Cited by 3774 |
Agreement is poor among current criteria used to define response to cardiac resynchronization therapy
…, WW Sprague, P BeDell, JD Suever, B Gerritse… - Circulation, 2010 - Am Heart Assoc
Background—Numerous criteria believed to define a positive response to cardiac
resynchronization therapy have been used in the literature. No study has investigated …
resynchronization therapy have been used in the literature. No study has investigated …
Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure
…, R Munoz Aguilera, M Lunati, CM Yu, B Gerritse… - Circulation, 2011 - Am Heart Assoc
Background—Heart failure is associated with frequent hospitalizations, often resulting from
volume overload. Measurement of intrathoracic impedance with an implanted device with an …
volume overload. Measurement of intrathoracic impedance with an implanted device with an …
Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling …
…, C Thébault, C Linde, WT Abraham, B Gerritse… - Circulation, 2012 - Am Heart Assoc
Background—Cardiac resynchronization therapy (CRT) decreases mortality, improves
functional status, and induces reverse left ventricular remodeling in selected populations …
functional status, and induces reverse left ventricular remodeling in selected populations …
Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) …
…, L Tavazzi, PJ Zimetbaum, B Gerritse… - European heart …, 2009 - academic.oup.com
Abstract Aims Predictors of Response to Cardiac Resynchronization Therapy
(CRT)(PROSPECT) was the first large-scale, multicentre clinical trial that evaluated the …
(CRT)(PROSPECT) was the first large-scale, multicentre clinical trial that evaluated the …
Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial
…, L Tavazzi, M Santini, F Oliva, B Gerritse… - European heart …, 2011 - academic.oup.com
Aims Early recognition of impending decompensation and timely intervention may prevent
heart failure (HF) hospitalization. We investigated the performance of OptiVol® intrathoracic …
heart failure (HF) hospitalization. We investigated the performance of OptiVol® intrathoracic …
Fluid status telemedicine alerts for heart failure: a randomized controlled trial
…, R Bosch, C Butter, G Klein, B Gerritse… - European Heart …, 2016 - academic.oup.com
Aims Hospital admissions are frequently preceded by increased pulmonary congestion in
heart failure (HF) patients. This study evaluated whether early automated fluid status alert …
heart failure (HF) patients. This study evaluated whether early automated fluid status alert …
Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular‐only …
…, D Birnie, MR Gold, B Gerritse… - European Journal of …, 2017 - Wiley Online Library
The AdaptResponse trial is designed to test the hypothesis that preferential adaptive left
ventricular‐only pacing with the AdaptivCRT® algorithm reduces the incidence of the …
ventricular‐only pacing with the AdaptivCRT® algorithm reduces the incidence of the …
Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial
…, E Donal, C Meunier, R Gervais, B Gerritse… - European heart …, 2012 - academic.oup.com
Objectives The objective of this study is to ascertain the effects of the left (LV) and right (RV)
ventricular lead tip position in response to cardiac resynchronization therapy (CRT) …
ventricular lead tip position in response to cardiac resynchronization therapy (CRT) …
ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy
…, S Tung, P Defaye, Z Yang, B Gerritse… - European heart …, 2016 - academic.oup.com
Abstract Aims The ALternate Site Cardiac ResYNChronization (ALSYNC) study evaluated
the feasibility and safety of left ventricular endocardial pacing (LVEP) using a market …
the feasibility and safety of left ventricular endocardial pacing (LVEP) using a market …
[HTML][HTML] Low inappropriate shock rates in patients with single-and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms …
A Auricchio, EJ Schloss, T Kurita, A Meijer, B Gerritse… - Heart Rhythm, 2015 - Elsevier
Background The benefits of implantable cardioverter-defibrillators (ICDs) have been well
demonstrated in many clinical trials, and ICD shocks for ventricular tachyarrhythmias save …
demonstrated in many clinical trials, and ICD shocks for ventricular tachyarrhythmias save …